Qujing Hengsheng Closes $14 Million Pre-A Round for Minimally Invasive Imaging

Qujing Hengsheng Science and Technology of Beijing, a medical device maker, closed a $14 million Pre-A funding to develop novel cardiovascular and intracavitary imaging technologies. The company's S1 intravascular imaging system combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT). Qujing Hengsheng claims each of the two technologies already surpass the performance of foreign-made technologies, while combining the two via a single catheter allows doctors to choose the best modality, reducing risk in percutaneous coronary intervention (PCI) procedures. More details.... Share this with colleagues: // //